Active Ingredient: NEOSTIGMINE METHYLSULFATE
Proprietary Name: NEOSTIGMINE METHYLSULFATE
Dosage Form; Route of Administration: SOLUTION; INTRAVENOUS
Strength: 5MG/10ML (0.5MG/ML)
Reference Listed Drug: No
Reference Standard: No
TE Code: AP
Application Number: A212627
Product Number: 001
Approval Date: Nov 3, 2022
Applicant Holder Full Name: NIVAGEN PHARMACEUTICALS INC
Marketing Status:
Prescription
Patent and Exclusivity Information
Active Ingredient: NEOSTIGMINE METHYLSULFATE
Proprietary Name: NEOSTIGMINE METHYLSULFATE
Dosage Form; Route of Administration: SOLUTION; INTRAVENOUS
Strength: 10MG/10ML (1MG/ML)
Reference Listed Drug: No
Reference Standard: No
TE Code: AP
Application Number: A212627
Product Number: 002
Approval Date: Nov 3, 2022
Applicant Holder Full Name: NIVAGEN PHARMACEUTICALS INC
Marketing Status:
Prescription
Patent and Exclusivity Information